Skip Nav Destination
Issues
1 February 2000
ISSN 1078-0432
EISSN 1557-3265
Editorial
Minireview
Advances in Brief
Clinical Trials
Successful Surgical Removal of Occult Metastases of Medullary Thyroid Carcinoma Recurrences with the Help of Immunoscintigraphy and Radioimmunoguided Surgery1
Claire de Labriolle-Vaylet; Pierre Cattan; Emile Sarfati; Michel Wioland; Claire Billotey; Claude Brochériou; Eric Rouvier; Anne de Roquancourt; William Rostène; Serge Askienazy; Jacques Barbet; Gérard Milhaud; Anne Gruaz-Guyon
Phase I Clinical and Pharmacokinetic Study of Perillyl Alcohol Administered Four Times a Day1
Gregory H. Ripple; Michael N. Gould; Rhoda Z. Arzoomanian; Dona Alberti; Chris Feierabend; Kris Simon; Kim Binger; Kendra D. Tutsch; Marcia Pomplun; Amy Wahamaki; Rebecca Marnocha; George Wilding; Howard H. Bailey
Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer1
Susan J. Knox; Michael L. Goris; Margaret Tempero; Paul L. Weiden; Louis Gentner; Hazel Breitz; Gregory P. Adams; Donald Axworthy; Sally Gaffigan; Kyle Bryan; Darrell R. Fisher; David Colcher; Ivan D. Horak; Louis M. Weiner
Modulation of Clinical Drug Resistance in a B Cell Lymphoma Patient by the Protein Kinase Inhibitor 7-Hydroxystaurosporine: Presentation of a Novel Therapeutic Paradigm
Wyndham H. Wilson; Lynn Sorbara; William D. Figg; Erik K. Mont; Edward Sausville; Katherine E. Warren; Frank M. Balis; Ken Bauer; Mark Raffeld; Adrian M. Senderowicz; Anne Monks
Molecular Oncology, Markers, Clinical Correlates
Significance of Neuron-specific Enolase Levels before and during Therapy for Small Cell Lung Cancer1
James A. Bonner; Jeff A. Sloan; Kendrith M. Rowland, Jr.; George G. Klee; John W. Kugler; James A. Mailliard; Martin Wiesenfeld; James E. Krook; Andrew W. Maksymiuk; Edward G. Shaw; Randolph S. Marks; Edith A. Perez
Experimental Therapeutics, Preclinical Pharmacology
Characterization of an Ovarian Carcinoma Cell Line Resistant to Cisplatin and Flavopiridol1
Keith C. Bible; Scott A. Boerner; Kathryn Kirkland; Kari L. Anderl; Duane Bartelt, Jr.; Phyllis A. Svingen; Timothy J. Kottke; Yean K. Lee; Steven Eckdahl; Paul G. Stalboerger; Robert B. Jenkins; Scott H. Kaufmann
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.